Transvaginal mesh is a medical device that is implanted in patients to treat Stress Urinary Incontinence (SUI) and Pelvic Organ Prolapse (POP). SUI typically develops in older women or in women after childbirth, with symptoms that include the leakage of urine during exercise and other physical activities. POP occurs when the vaginal wall becomes weakened or stretched and the pelvic organs prolapse into the vagina.
Doctors often implant transvaginal mesh to repair the effects of SUI and POP and reinforce the weakened vaginal wall.
Many serious conditions have occurred as a result of implantation, including migration of the mesh into the vagina and uterus, organ perforation and scarring. Additional complications after transvaginal mesh implantation include pain, infection and other life-altering health issues, and very often require immediate medical attention and even surgery to remove it.
In 2008, the FDA issued a public health notification reporting more than 1,000 adverse events related to the implantation of transvaginal mesh in the three previous years. In 2011, the FDA issued an updated report, warning the public that the serious complications associated with transvaginal mesh are not rare and that using mesh is not necessarily a more effective alternative to the traditional, non-mesh surgical repair.
If you are an implant recipient of transvaginal mesh to repair POP or SUI and have developed serious complications, please contact Slack Davis Sanger for a free consultation. Our team of experienced professionals includes a full-time legal nurse consultant, as well as medical device attorneys who have successfully fought cases against companies such as Guidant Corporation, Smith & Nephew, Sulzer Orthopedics, American Home Products, Bayer, Merck, Wyeth and others.